biote Corp. (BTMD) Stock Forecast
BTMD analyst forecast
as of October 17, 2026- Analyst consensus
- Strong buy 4.60 / 5 from 5 analysts
- Price target
- $2.61 average of analyst targets
- Upside to target
- +140.7% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $-0.05
- 52-week range
- $1.04 – $3.19
BTMD analyst ratings
5 analystsNumber of analysts at each rating.
BTMD price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
BTMD earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.04 | $0.04 | $0.04 | $0.18 | −77.5% | 1 |
| Current fiscal year (2026) | $0.35 | $0.35 | $0.35 | $0.56 | −37.7% | 1 |
| Next fiscal year (2027) | $0.45 | $0.45 | $0.45 | $0.35 | +28.6% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
BTMD revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $44.0M | $43.4M | $44.8M | −8.2% | 4 |
| Current fiscal year (2026) | $177.9M | $176.2M | $179.4M | −7.4% | 4 |
| Next fiscal year (2027) | $187.6M | $184.1M | $190.1M | +5.5% | 4 |
BTMD EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
BTMD revenue: reported and forecast
BTMD EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.12 | $0.12 | $0.12 | $0.12 | $0.04 | −66.7% | 0 up · 1 down |
| Current fiscal year (2026) | $0.49 | $0.49 | $0.49 | $0.49 | $0.35 | −28.6% | 0 up · 1 down |
| Next fiscal year (2027) | $0.57 | $0.57 | $0.57 | $0.57 | $0.45 | −21.1% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
BTMD earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; BTMD beat in 10 of 12.
What analysts expect from BTMD
5 analysts cover biote; their consensus rating is strong buy (4.60 on a 1–5 scale, where 5 is a strong buy). The average price target is $2.61, 140.7% above the latest close of $1.08. Analysts expect earnings of $0.35 per share for 2026, −37.7% from a year earlier. For 2027 the average estimate is $0.45 per share on revenue of $187.6 million. biote beat the EPS estimate in 10 of the last 12 quarters.
Related: BTMD income statement, BTMD key metrics, BTMD chart. See the BTMD stock overview for the latest quote and news.
BTMD forecast FAQ
What is biote's price target?
The average analyst price target for biote is $2.61, 140.7% above the latest close of $1.08.
Is biote a buy, hold or sell?
Of 5 analysts covering biote, 4 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is biote's EPS forecast?
Analysts forecast $0.35 per share for 2026 (range $0.35 to $0.35); for 2027 the estimate is $0.45.
What is biote's revenue forecast?
The average revenue estimate for 2026 is $177.9 million, growth of −7.4%; for 2027 it is $187.6 million.
When does biote report earnings?
biote is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 after the market closes; the EPS estimate is $-0.05.
Does biote usually beat earnings estimates?
biote reported EPS at or above the analyst estimate in 10 of the last 12 quarters.